Cite

HARVARD Citation

    Coulibaly, D. et al. (2022). PfSPZ-CVac malaria vaccine demonstrates safety among malaria-experienced adults: A randomized, controlled phase 1 trial. EClinicalMedicine. p. . [Online]. 
  
Back to record